Schedule 13G
HIMS Schedule 13G filing by JPMorgan Chase / Asset Management
JPMorgan Chase / Asset Management reported beneficial ownership of 17.8M shares, representing 12% of Hims & Hers Health, Inc. in this filing.
FiledOct 31, 2025
Ownership dateSep 30, 2025
Reported shares17.8M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
16.0M
Shared voting power
17.8M
Sole dispositive power
17.8M
Shared dispositive power
17.8M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$45.46as of Oct 31, 2025
Latest tracked price$31.99as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- JPMorgan Chase / Asset Management
- CIK
- CIK0000019617
- Accession
- 0000019617-25-001056
- Form
- Schedule 13G
Read the filing in context